Please login to the form below

Not currently logged in
Email:
Password:

J&J and Hanmi collaborate on diabetes and obesity

Alliance worth up to$915m
J&J

Johnson and Johnson have entered into an alliance with Hanmi Pharmaceuticals to develop new treatments for diabetes and obesity.

The alliance involves the development and commercialisation of oxyntomodulin-based therapies, including Hanmi's HM12525A, a novel biologic GLP-1/Glucagon dual receptor agonist to treat diabetes and obesity, which is expected to enter phase II trials next year.

James List, global therapeutic area head of cardiovascular and metabolism and J&J's Janssen unit, said: “We are very excited about this agreement with Hanmi and the potential of HM1252A to improve therapeutic options for people living with metabolic diseases.

“Our deep scientific expertise and demonstrated clinical development capabilities support our commitment to aggressively develop and launch transformational therapies for patients with cardiovascular and metabolic diseases.

“We look forward to developing this potential best-in-class therapy.”

Under the terms of the agreement J&J will obtain exclusive worldwide rights, except in China and Korea, to develop and commercialise HM12525A.

Hanmi will receive a payment of $105m and is also eligible to receive up to $810m in potential clinical development, regulatory and sales milestones.

Additionally if HM12525A is successfully commercialised, Hanmi would receive double-digit royalty payments. 

Article by
Nikhil Patel

13th November 2015

From: Research

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
BOLDSCIENCE

We know what it takes to create brands, to start new conversations, to simply communicate complex science, to change lives…...

Latest intelligence

reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history....
Looking back at the year when everything changed
COVID-19 has impacted every aspect of our lives, from the way we shop for groceries to the way we conduct work and interact with healthcare providers and our families....

Infographics